Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761.

@article{Smith2003ElevationOO,
  title={Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761.},
  author={Julie Vining Smith and Yuan Luo},
  journal={Journal of Alzheimer's disease : JAD},
  year={2003},
  volume={5 4},
  pages={
          287-300
        }
}
  • J. Smith, Yuan Luo
  • Published 2003
  • Biology, Medicine
  • Journal of Alzheimer's disease : JAD
The role of amyloid beta-peptide (Abeta) in the free-radical oxidative-stress model of neurotoxicity in Alzheimer's disease (AD) has received much attention recently. In this study, we have employed both in vitro and in vivo models displaying endogenous Abeta production to study the effects of Abeta on intracellular free radical levels. We employed a neuroblastoma cell line stably expressing an AD-associated double mutation, which exhibits both increased secretion and intracellular accumulation… Expand
Hyperbaric Oxygen and Ginkgo Biloba Extract Inhibit Aβ25-35-induced Toxicity and Oxidative Stress in vivo: A Potential Role in Alzheimer's Disease
TLDR
The results suggest that both HBO and EGB761 may relieve cell toxicity and oxidative stress in AD and thus play a potential protective role in AD. Expand
β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
TLDR
It is demonstrated that Aβ accumulation in neuronal cells correlated with neuronal iron homeostasis disruption and probably contributed to the pathogenesis of AD. Expand
Centella asiatica extract protects against amyloid β1–40-induced neurotoxicity in neuronal cells by activating the antioxidative defence system
TLDR
C. asiatica ethanol extract-mediated protection against aggregated Aβ1–40-induced neurotoxicity is attributable to modulation of the antioxidative defense system in cells, including the activities of superoxide dismutase, catalase, glutathione peroxidase,glutathione reductase, and levels of glutATHione and glutathion disulfide by CAE. Expand
Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans
TLDR
It is reported that EGb 761 and one of its components, ginkgolide A, alleviates Aβ-induced pathological behaviors, including paralysis, and reduces chemotaxis behavior and 5-HT hypersensitivity in a transgenic C. elegans. Expand
Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer’s disease
TLDR
Long-term treatment with G. biloba extract EGb 761, a clinically available and well-tolerated herbal medication, ameliorates AD pathology by antiinflammatory and Aβ-directed mechanisms. Expand
Inhibition of Abeta Proteotoxicity by Paeoniflorin in Caenorhabditis elegans Through Regulation of Oxidative and Heat Shock Stress Responses.
TLDR
It is demonstrated here that paeoniflorin can delay progressive paralysis caused by endogenous Aβ expression and reduce the amount of toxic Aβ oligomers in vivo, although it has no effect on Aβ aggregation in vitro. Expand
Coumarin derivatives protection against ROS production in cellular models of Aβ toxicities
TLDR
These coumarin derivatives were tested as H2O2 scavengers with the DCF assay and their protective role against cell death further supports this notion that these compounds could be used as a template in the design of new molecules with a possible role in AD. Expand
Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans
TLDR
Findings suggest that a specific soy isoflavone glycitein may suppress Aβ toxicity through combined antioxidative activity and inhibition of Aβ deposition, thus may have therapeutic potential for prevention of A β associated neurodegenerative disorders. Expand
In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid β-peptide (1–42)-induced oxidative stress
TLDR
It is suggested that tricyclodecan-9-yl-xanthogenate is a potent antioxidant and could be of importance for the treatment of Alzheimer's disease and other oxidative stress-related disorders. Expand
Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
TLDR
Current data indicate that APP seems to be an important molecular target of EGb761 in relation to the duration of the Ginkgo biloba treatment and/or the age of the animals, and potential neuroprotective properties of EG b761 may be, at least partly, related to its APP lowering activity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 67 REFERENCES
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
  • Yuan Luo, J. Smith, +7 authors P. Butko
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2002
TLDR
It is reported that EGb761 inhibits formation of amyloid-β (Aβ) fibrils, which are the diagnostic, and possibly causative, feature of AD, and suggests that neuronal damage in AD might be due to a direct Aβ toxicity and the apoptosis initiated by the mitochondria. Expand
Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production.
TLDR
It is reported that the increased protein oxidation, reactive oxygen species (ROS) formation, and neurotoxicity induced by Abeta(1-42) in primary rat embryonic hippocampal neuronal culture are prevented by the free radical scavenger and antioxidant vitamin E. Expand
Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model
TLDR
The increased oxidative stress in CL4176 occurred in the absence of Abeta fibril formation, consistent with the notion that the toxic species in Abeta toxicity is pre-fibrillar Abeta and not the Abetafibril. Expand
In Vitro and in vivo Protein Oxidation Induced by Alzheimer's Disease Amyloid β‐Peptide (1–42)
TLDR
A comprehensive hypothesis for neurotoxicity in AD brain is developed and an Aβ-associated free radical oxidative stress model for neuronal death inAD brain is proposed, providing evidence for Aβ(1-42)–induced ROS generation in vitro and protein oxidation in vivo and in vivo. Expand
In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42)
TLDR
In vitro and in vivo models of beta-amyloid (A beta) toxicity are used to detect free radical induced oxidative stress by the measure of protein carbonyl levels, and the hypothesis that methionine is important in A beta-associated free radical oxidative stress is supported. Expand
Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide.
  • L. Zhou, X. Zhu
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
  • 2000
TLDR
Bilobalide may block the apoptosis in the early stage and then attenuate the elevation of c-Myc, p53, and Bax and activation of caspase-3 in cells. Expand
Vitamin Ε as an Antioxidant/Free Radical Scavenger Against Amyloid β-Peptide-Induced Oxidative Stress in Neocortical Synaptosomal Membranes and Hippocampal Neurons in Culture: Insights into Alzheimer's Disease
Amyloid beta-peptide (Abeta), the major constituent in senile plaques in Alzheimer's disease (AD) brain, is thought by many researchers to be central to neurotoxicity in AD brain. Increasing evidenceExpand
Free radicals and lipid peroxidation do not mediate β-amyloid-induced neuronal cell death
TLDR
Results indicate that free radicals and lipid peroxidation may not mediate Aβ-induced neurotoxicity and that treatment with these anti-oxidants did not rescue the cells from A β-induced apoptosis and cell death. Expand
Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease.
  • Yuan Luo
  • Medicine
  • Journal of Alzheimer's disease : JAD
  • 2001
TLDR
Better understanding of the neuroprotective mechanisms of EGb761 will provide impetus for possible combination therapies and for the design of rational, "mechanism-based" strategies that target age-related neurodegeneration and Alzheimer's disease. Expand
Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761.
TLDR
EGb 761 afforded protection against oxidative damage in all the systems the authors analyzed and is an efficient scavenger of peroxyl radicals, which supports the hypothesis of an antioxidant therapeutic action of EGb 7 61. Expand
...
1
2
3
4
5
...